Research and Development

Innovation Investment Product Development Investment Strategies AI Research Collaborations Technology Innovation Innovations Biotechnology Automotive Technology Energy Sector Funding Partnerships Automotive R&D Innovative Technologies Innovation in Technology Patents Scientific Research AI in Industry Technology Investment AI Development R&D Expenses Grants Commercialization Sustainable Practices Product Innovation Clinical Trials Open Source Software Technology Development Environmental Technology Collaborative Research Collaborative Projects Quantum Technology Intellectual Property Cost Reduction Open Science Innovation Strategies Biotechnology Industry Battery Technology Chemical Industry Technology Companies Industry Collaboration Pharmaceuticals Innovative Solutions Cost Management Automotive Industry Agricultural Technology Collaboration Innovations in Technology Scientific Innovation R&D Investment Innovative Materials Pharmaceutical Companies Drug Development Innovation in Automotive Funding Initiatives Engineering Open Source Projects Weather Technology Technology Transfer Industrial Applications Intellectual Property Management AI Companies University of Birmingham Vaccines Applications Technology Sector OpenAI Technology in Weather Forecasting Enterprise Applications Joint Research Innovation in Energy Technologies Technology Collaboration Policy Recommendations Funding Agencies Material Science Cooperative Agreements Patent Registration Innovation Strategy Therapeutics Development Capital Expenditure Global R&D Operations Product Consistency EU Research Programs Cost Analysis Technological Institutes University Contributions Electric Vehicles Energy Solutions Space Technology Generative Artificial Intelligence Pharmaceutical Industry Alibaba Group Advancing Research Plan Consumer Technology Private Sector AUR200 Meteorological Services Innovation in Medicine Public-Private Partnerships

Claude AI Designed Lab‑Confirmed Protein Binders for 14 of 15 Disease Targets

Lab builds confirmed about 27% of Claude's de novo designs bound, suggesting early drug discovery is now limited by compute and wet‑lab throughput.

White House Prioritizes Undersea, Space and AI in New Science‑and‑Technology Strategy

Callosum Raises $100 Million Seed to Orchestrate AI Across Diverse Chips

Clemson Unveils Student-Built Solar EV That Models Net-Positive Daily Energy

Londian Wason Prices Upsized IPO and Debuts on NYSE at $2.01 Billion Valuation

DeepMind’s WeatherNext Gives Forecasters an Extra Day of Hurricane Lead Time

AstraZeneca Beats Q2 Estimates and Reaffirms 2026 Guidance

Nio Shifts to Partner-Led UK Path as Firefly Begins Right‑Hand‑Drive Production

HCW Biologics Posts Surprise Q1 Profit on Trimmune Deal as Listing Risk Lingers

GSI Technology Reports FY2026 Results as Gemini‑II Moves Toward June Defense Demo

Rivian Weighs U.S. Lidar Production Using Chinese Technology

Hybrid Quantum Effort Simulates 12,635-Atom Protein Complexes

Dreame Debuts FP10 Air Purifier With Self-Cleaning Roller for Pet Hair

Neogen Lifts Sales Outlook After Mixed Quarter as Margins Improve

PetroChina Posts 2025 Profit Dip as Cash Flow and Output Climb

Chemistry Advances Push All-Perovskite Tandems Toward 30% With Stronger Stability

IBM Quantum Processor Reproduces Neutron-Scattering Data for Real Magnetic Crystal

Humanoid Robot Learns Tennis From Imperfect Human Motion, Posts High Real-World Success

IBM Publishes First Reference Architecture for Quantum‑Centric Supercomputing

Aletheia Debuts as Gemini-Based AI Math Research Agent With Claimed Research Results